SAVE (Sleep Apnea cardioVascular Endpoints) is an international study, attempting to discover if the use of CPAP can reduce the risk of heart attack, stroke or heart failure in patients with OSA. As a member of the Australasian Sleep Trials Network, the Woolcock Insitute of Medical Research is supporting this important research study.

The study is coordinated internationally by another medical research organization, The George Institute for Global Health in collaboration with the Adelaide Institute of Sleep Health. The George Institute oversees recruitment globally. Participating study centres in Sydney include Royal Prince Alfred Hospital and Concord Repatriation General Hospital.

If you are interested in volunteering, or would like to find out more about the SAVE Study, please follow this link to an external site:

http://www.savetrial.org/participant_information

This link was placed by Dr Keith Wong of the Woolcock Institute Sleep and Circadian Research Group